Omnimmune
(OTC) OMMH
This security has been delisted. This page is retained for historical reference.
OMMH News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowOMMH Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
38%
Return on Capital
35%
Return on Assets
-56%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
-$1.52M
EBITDA
-$1.52M
Operating Cash Flow
-$252.43K
Capital Expenditure
$0.00
Free Cash Flow
-$252.43K
Cash & ST Invst.
$5.63K
Total Debt
$2.27M
Omnimmune Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
2
N/A
Net Income
-$303.50K
+34.3%
EBITDA
-$224.77K
+44.0%
Quarterly Fundamentals
Net Cash
-$2.28M
-0.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$1.05M
+2.5%
Short Term Debt
$1.23M
-1.0%
Return on Assets
-56.03%
N/A
Return on Invested Capital
34.65%
N/A
Free Cash Flow
-$76.61K
-138.1%
Operating Cash Flow
-$76.61K
-138.1%